Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONFIRM-2: Vatalanib + FOLFOX in 2nd-line mCRC
NCT00056446Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2003
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of vatalanib in metastatic colorectal cancer (mCRC), sponsored by Novartis. Started Jan 2003; status: completed.
02
Drugs
vatalanib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00056446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056446.